CJC/Ipamorelin 5mg+5mg

Description

CJC-1295 / Ipamorelin 5mg + 5mg is a dual-peptide research blend formulated for studies involving growth hormone signaling pathways.

CJC-1295 is a synthetic analog of Growth Hormone Releasing Hormone (GHRH), studied for its ability to stimulate natural growth hormone (GH) release via GHRH receptor activation. Ipamorelin is a selective growth hormone secretagogue that interacts with ghrelin (GHS-R1a) receptors, promoting GH release through a complementary mechanism.

When studied together in controlled research settings, this peptide combination has been observed to enhance pulsatile growth hormone signaling while maintaining receptor selectivity. Growth hormone and IGF-1 pathways are involved in multiple physiological processes including protein synthesis signaling, metabolic regulation, endocrine balance, and cellular recovery mechanisms.

Because these peptides act through distinct yet complementary receptor pathways, the CJC-1295 / Ipamorelin blend is frequently examined in research models evaluating coordinated GH modulation and endocrine system response.

Each vial contains 5mg CJC-1295 and 5mg Ipamorelin in a stable lyophilized format. Every batch is HPLC tested to confirm ≥99% purity and ensure research-grade consistency.

Product Specifications:

• Peptide Blend: CJC-1295 5mg + Ipamorelin 5mg

• Total Content: 10mg per vial

• Purity: ≥99% (HPLC tested)

• Form: Lyophilized powder in sterile vial

• Appearance: White to off-white lyophilized cake

• Grade: Research Use Only (RUO)

• Storage: Refrigerate after reconstitution

• Certificate of Analysis: Available upon request

⚠ This product is sold strictly for laboratory research purposes only. Not intended to diagnose, treat, cure, or prevent any disease.